Resistance development of MRSA has become a global health problem. New resistance types, such as vancomycin-resistant S. aureus, have been recently developed. Novel antibiotics, such as linezolid ...

When that happens, your infection will be said to be antibiotic resistant, and your physician will have to prescribe a different drug to combat it. MRSA: The Spread of Drug Resistance In fact ...

Antibiotics are ubiquitous within the ... Methicillin-resistant staphylococcus aureus (MRSA) is probably the best known superbug. First observed in 1960, MRSA continued to increase slowly in ...

MRSA (pronounced MUR-suh), seen here as purple spheres, is the abbreviation for methicillin-resistant Staphylococcus aureus, an antibiotic-resistant bacterium that can cause a severe infection in ...

The new research, led by the University of Sheffield, reveals MRSA has a double defence mechanism against antibiotics - this new insight offers hope in treating the life-threatening superbug and ...

Tygacil (tigecycline)is a new, expanded broad-spectrum IV antibiotic that can be used for ... as methicillin-resistant Staphylococcus aureus (MRSA). It will be available in the UK from today.

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to many antibiotics, making infections difficult to treat. Surveillance of MRSA is crucial in healthcare ...

Testing market is projected to expand steadily over the next decade, rising from an estimated USD 4.3 billion in 2025 to USD ...